daily doses) for 750 mg, BID is 35.2. [2] In this series, of the 12 patients with MIC less than or equal to 0.25 μg/μl, only one patient had an MIC of 0.25 μg/μl and he was continued on therapy with ceftriaxone for 14 days.
During this period, 96 Nalidixic Acid Resistant Salmonella Typhi (NARST) were isolated from this lot, The percentage of NARST isolated at the institute was 93.2%.
Agar dilution, as recommended by CLSI guidelines, was used in MIC determination. Medical records and clinical outcome of only 20 admitted patients could be accessed as since most patients are referred to our laboratory from across the city for only blood culture and medical records for these out patient referrals are not available. In seven patients, clinical failure with fluoroquinolones, given prior to admission, was recorded. Blood culture was positive in all of these seven, revealing microbiological failure. As part of the institution antibiotic policy, suspected patients of enteric fever, failing treatment on fluoroquinolones and warranting admission are empirically treated with ceftriaxone.
The
Pharmacokinetic/Pharmacodynamic (PK/PD) measure, that is most predictive of efficacy, is indeed the free drug area under the concentration time curve from zero to 24 hours to the MIC ratio, with a ratio of 105 corresponding to 90% maximal activity. Simulation results suggest ciprofloxacin susceptible breakpoints of 0.12 pg/ ml.
[1] The AUC (mg/L.h), at a steady state (calculated as equivalent to AUC for single dose multiplexed by number of
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PPTCT of HIV: Two and a Half Year Experience at MKCG Medical College, Berhampur, India
Dear Editor,
The Prevention of parent-to-child transmission of HIV/ AIDS (PPTCT) programme was started in India in the year 2002, following a feasibility study in 11 major hospitals in the five HIV prevalence states. Currently, there are more than 4000 integrated counselling and testing centers (ICTCs) which offer PPTCT services to pregnant women. Of these ICTCs, 502 are in the Obstetrics and Gynaecology departments and maternity homes where the client load is predominantly pregnant women. The joint technical mission on PPTCT (2006) estimated that out of 27 million annual pregnancies in India, 189,000 occur in HIV-positive pregnant women. In the absence of any intervention, an estimated cohort of 56,700 infected babies will be born annually.
[1] The PPTCT programme aims to prevent peri-natal transmission of HIV from an HIV infected pregnant mother to her newborn baby. The program entails
